Global Competent Cells Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 22-Apr-2020
No. of pages: 128
Inquire Before Buying

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

Asia-Pacific has the largest global export quantity and manufacturers in Competent Cells market, while the North America is the second sales volume market for Competent Cells in 2016.

In the industry, Merck KGaA profits most in 2016 and recent years, while Thermo Fisher Scientific and Agilent Technologies ranked 2 and 3.The market share of them is 13.28%, 9.52% and 7.00% in 2016.The gap of market share is keep on enlarged due to different strategy.

Nowadays, there are two mainly types of Competent Cells, including Chemically Competent Cells and Electrocompetent Cells. And Chemically Competent Cells is the main type for Competent Cells, and the Chemically Competent Cells reached a sales volume of approximately 42236 K Unit in 2016, with 64.12% of global sales volume.

Competent Cells technology is much mature now, and new enterprises can not surpass existing famous brands on reputation or design in the short term. So, the study group recommends the new entrants need to be considered carefully before enter into this field.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Competent Cells market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Competent Cells industry.

Based on our recent survey, we have several different scenarios about the Competent Cells YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1662.9 million in 2019. The market size of Competent Cells will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Competent Cells market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Competent Cells market in terms of revenue.

Players, stakeholders, and other participants in the global Competent Cells market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Competent Cells market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Competent Cells market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Competent Cells market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Competent Cells market.

The following players are covered in this report:

- Merck KGaA

- Thermo Fisher Scientific

- Agilent Technologies

- Takara Bio

- Promega Corporation

- Beijing TransGen Biotech

- GeneScript Corporation

- Yeastern Biotech

- New England Biolabs

- QIAGEN N.V.

- OriGene Technologies

- Lucigen

- Zymo Research

- Bio-Rad Laboratories

- Bioline

- Delphi Genetics

- IBA GmBH

- Cell Applications

- BioDynamics Laboratory

- Scarab Genomics

- GCC Biotech

- SMOBIO Technology

- Edge BioSystems

Competent Cells Breakdown Data by Type

- Chemically Competent Cells

- Electrocompetent Cells

Competent Cells Breakdown Data by Application

- Subcloning & Routine Cloning

- Phage Display Library Construction

- Toxic/Unstable DNA Cloning

- High-Throughput Cloning

- Protein Expression

- Mutagenesis

- Single-Stranded DNA Production

- Bacmid creation

- Cre-lox recombination (PIR1/PIR2)

Global Competent Cells Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Competent Cells Revenue
1.4 Market Analysis by Type
1.4.1 Global Competent Cells Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemically Competent Cells
1.4.3 Electrocompetent Cells
1.5 Market by Application
1.5.1 Global Competent Cells Market Share by Application: 2020 VS 2026
1.5.2 Subcloning & Routine Cloning
1.5.3 Phage Display Library Construction
1.5.4 Toxic/Unstable DNA Cloning
1.5.5 High-Throughput Cloning
1.5.6 Protein Expression
1.5.7 Mutagenesis
1.5.8 Single-Stranded DNA Production
1.5.9 Bacmid creation
1.5.10 Cre-lox recombination (PIR1/PIR2)
1.6 Coronavirus Disease 2019 (Covid-19): Competent Cells Industry Impact
1.6.1 How the Covid-19 is Affecting the Competent Cells Industry
1.6.1.1 Competent Cells Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Competent Cells Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Competent Cells Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Competent Cells Market Perspective (2015-2026)
2.2 Competent Cells Growth Trends by Regions
2.2.1 Competent Cells Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Competent Cells Historic Market Share by Regions (2015-2020)
2.2.3 Competent Cells Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Competent Cells Market Growth Strategy
2.3.6 Primary Interviews with Key Competent Cells Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Competent Cells Players by Market Size
3.1.1 Global Top Competent Cells Players by Revenue (2015-2020)
3.1.2 Global Competent Cells Revenue Market Share by Players (2015-2020)
3.1.3 Global Competent Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Competent Cells Market Concentration Ratio
3.2.1 Global Competent Cells Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Competent Cells Revenue in 2019
3.3 Competent Cells Key Players Head office and Area Served
3.4 Key Players Competent Cells Product Solution and Service
3.5 Date of Enter into Competent Cells Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Competent Cells Historic Market Size by Type (2015-2020)
4.2 Global Competent Cells Forecasted Market Size by Type (2021-2026)
5 Competent Cells Breakdown Data by Application (2015-2026)
5.1 Global Competent Cells Market Size by Application (2015-2020)
5.2 Global Competent Cells Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Competent Cells Market Size (2015-2020)
6.2 Competent Cells Key Players in North America (2019-2020)
6.3 North America Competent Cells Market Size by Type (2015-2020)
6.4 North America Competent Cells Market Size by Application (2015-2020)
7 Europe
7.1 Europe Competent Cells Market Size (2015-2020)
7.2 Competent Cells Key Players in Europe (2019-2020)
7.3 Europe Competent Cells Market Size by Type (2015-2020)
7.4 Europe Competent Cells Market Size by Application (2015-2020)
8 China
8.1 China Competent Cells Market Size (2015-2020)
8.2 Competent Cells Key Players in China (2019-2020)
8.3 China Competent Cells Market Size by Type (2015-2020)
8.4 China Competent Cells Market Size by Application (2015-2020)
9 Japan
9.1 Japan Competent Cells Market Size (2015-2020)
9.2 Competent Cells Key Players in Japan (2019-2020)
9.3 Japan Competent Cells Market Size by Type (2015-2020)
9.4 Japan Competent Cells Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Competent Cells Market Size (2015-2020)
10.2 Competent Cells Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Competent Cells Market Size by Type (2015-2020)
10.4 Southeast Asia Competent Cells Market Size by Application (2015-2020)
11 India
11.1 India Competent Cells Market Size (2015-2020)
11.2 Competent Cells Key Players in India (2019-2020)
11.3 India Competent Cells Market Size by Type (2015-2020)
11.4 India Competent Cells Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Competent Cells Market Size (2015-2020)
12.2 Competent Cells Key Players in Central & South America (2019-2020)
12.3 Central & South America Competent Cells Market Size by Type (2015-2020)
12.4 Central & South America Competent Cells Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck KGaA
13.1.1 Merck KGaA Company Details
13.1.2 Merck KGaA Business Overview and Its Total Revenue
13.1.3 Merck KGaA Competent Cells Introduction
13.1.4 Merck KGaA Revenue in Competent Cells Business (2015-2020))
13.1.5 Merck KGaA Recent Development
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Details
13.2.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.2.3 Thermo Fisher Scientific Competent Cells Introduction
13.2.4 Thermo Fisher Scientific Revenue in Competent Cells Business (2015-2020)
13.2.5 Thermo Fisher Scientific Recent Development
13.3 Agilent Technologies
13.3.1 Agilent Technologies Company Details
13.3.2 Agilent Technologies Business Overview and Its Total Revenue
13.3.3 Agilent Technologies Competent Cells Introduction
13.3.4 Agilent Technologies Revenue in Competent Cells Business (2015-2020)
13.3.5 Agilent Technologies Recent Development
13.4 Takara Bio
13.4.1 Takara Bio Company Details
13.4.2 Takara Bio Business Overview and Its Total Revenue
13.4.3 Takara Bio Competent Cells Introduction
13.4.4 Takara Bio Revenue in Competent Cells Business (2015-2020)
13.4.5 Takara Bio Recent Development
13.5 Promega Corporation
13.5.1 Promega Corporation Company Details
13.5.2 Promega Corporation Business Overview and Its Total Revenue
13.5.3 Promega Corporation Competent Cells Introduction
13.5.4 Promega Corporation Revenue in Competent Cells Business (2015-2020)
13.5.5 Promega Corporation Recent Development
13.6 Beijing TransGen Biotech
13.6.1 Beijing TransGen Biotech Company Details
13.6.2 Beijing TransGen Biotech Business Overview and Its Total Revenue
13.6.3 Beijing TransGen Biotech Competent Cells Introduction
13.6.4 Beijing TransGen Biotech Revenue in Competent Cells Business (2015-2020)
13.6.5 Beijing TransGen Biotech Recent Development
13.7 GeneScript Corporation
13.7.1 GeneScript Corporation Company Details
13.7.2 GeneScript Corporation Business Overview and Its Total Revenue
13.7.3 GeneScript Corporation Competent Cells Introduction
13.7.4 GeneScript Corporation Revenue in Competent Cells Business (2015-2020)
13.7.5 GeneScript Corporation Recent Development
13.8 Yeastern Biotech
13.8.1 Yeastern Biotech Company Details
13.8.2 Yeastern Biotech Business Overview and Its Total Revenue
13.8.3 Yeastern Biotech Competent Cells Introduction
13.8.4 Yeastern Biotech Revenue in Competent Cells Business (2015-2020)
13.8.5 Yeastern Biotech Recent Development
13.9 New England Biolabs
13.9.1 New England Biolabs Company Details
13.9.2 New England Biolabs Business Overview and Its Total Revenue
13.9.3 New England Biolabs Competent Cells Introduction
13.9.4 New England Biolabs Revenue in Competent Cells Business (2015-2020)
13.9.5 New England Biolabs Recent Development
13.10 QIAGEN N.V.
13.10.1 QIAGEN N.V. Company Details
13.10.2 QIAGEN N.V. Business Overview and Its Total Revenue
13.10.3 QIAGEN N.V. Competent Cells Introduction
13.10.4 QIAGEN N.V. Revenue in Competent Cells Business (2015-2020)
13.10.5 QIAGEN N.V. Recent Development
13.11 OriGene Technologies
10.11.1 OriGene Technologies Company Details
10.11.2 OriGene Technologies Business Overview and Its Total Revenue
10.11.3 OriGene Technologies Competent Cells Introduction
10.11.4 OriGene Technologies Revenue in Competent Cells Business (2015-2020)
10.11.5 OriGene Technologies Recent Development
13.12 Lucigen
10.12.1 Lucigen Company Details
10.12.2 Lucigen Business Overview and Its Total Revenue
10.12.3 Lucigen Competent Cells Introduction
10.12.4 Lucigen Revenue in Competent Cells Business (2015-2020)
10.12.5 Lucigen Recent Development
13.13 Zymo Research
10.13.1 Zymo Research Company Details
10.13.2 Zymo Research Business Overview and Its Total Revenue
10.13.3 Zymo Research Competent Cells Introduction
10.13.4 Zymo Research Revenue in Competent Cells Business (2015-2020)
10.13.5 Zymo Research Recent Development
13.14 Bio-Rad Laboratories
10.14.1 Bio-Rad Laboratories Company Details
10.14.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
10.14.3 Bio-Rad Laboratories Competent Cells Introduction
10.14.4 Bio-Rad Laboratories Revenue in Competent Cells Business (2015-2020)
10.14.5 Bio-Rad Laboratories Recent Development
13.15 Bioline
10.15.1 Bioline Company Details
10.15.2 Bioline Business Overview and Its Total Revenue
10.15.3 Bioline Competent Cells Introduction
10.15.4 Bioline Revenue in Competent Cells Business (2015-2020)
10.15.5 Bioline Recent Development
13.16 Delphi Genetics
10.16.1 Delphi Genetics Company Details
10.16.2 Delphi Genetics Business Overview and Its Total Revenue
10.16.3 Delphi Genetics Competent Cells Introduction
10.16.4 Delphi Genetics Revenue in Competent Cells Business (2015-2020)
10.16.5 Delphi Genetics Recent Development
13.17 IBA GmBH
10.17.1 IBA GmBH Company Details
10.17.2 IBA GmBH Business Overview and Its Total Revenue
10.17.3 IBA GmBH Competent Cells Introduction
10.17.4 IBA GmBH Revenue in Competent Cells Business (2015-2020)
10.17.5 IBA GmBH Recent Development
13.18 Cell Applications
10.18.1 Cell Applications Company Details
10.18.2 Cell Applications Business Overview and Its Total Revenue
10.18.3 Cell Applications Competent Cells Introduction
10.18.4 Cell Applications Revenue in Competent Cells Business (2015-2020)
10.18.5 Cell Applications Recent Development
13.19 BioDynamics Laboratory
10.19.1 BioDynamics Laboratory Company Details
10.19.2 BioDynamics Laboratory Business Overview and Its Total Revenue
10.19.3 BioDynamics Laboratory Competent Cells Introduction
10.19.4 BioDynamics Laboratory Revenue in Competent Cells Business (2015-2020)
10.19.5 BioDynamics Laboratory Recent Development
13.20 Scarab Genomics
10.20.1 Scarab Genomics Company Details
10.20.2 Scarab Genomics Business Overview and Its Total Revenue
10.20.3 Scarab Genomics Competent Cells Introduction
10.20.4 Scarab Genomics Revenue in Competent Cells Business (2015-2020)
10.20.5 Scarab Genomics Recent Development
13.21 GCC Biotech
10.21.1 GCC Biotech Company Details
10.21.2 GCC Biotech Business Overview and Its Total Revenue
10.21.3 GCC Biotech Competent Cells Introduction
10.21.4 GCC Biotech Revenue in Competent Cells Business (2015-2020)
10.21.5 GCC Biotech Recent Development
13.22 SMOBIO Technology
10.22.1 SMOBIO Technology Company Details
10.22.2 SMOBIO Technology Business Overview and Its Total Revenue
10.22.3 SMOBIO Technology Competent Cells Introduction
10.22.4 SMOBIO Technology Revenue in Competent Cells Business (2015-2020)
10.22.5 SMOBIO Technology Recent Development
13.23 Edge BioSystems
10.23.1 Edge BioSystems Company Details
10.23.2 Edge BioSystems Business Overview and Its Total Revenue
10.23.3 Edge BioSystems Competent Cells Introduction
10.23.4 Edge BioSystems Revenue in Competent Cells Business (2015-2020)
10.23.5 Edge BioSystems Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Competent Cells Key Market Segments
Table 2. Key Players Covered: Ranking by Competent Cells Revenue
Table 3. Ranking of Global Top Competent Cells Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Competent Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemically Competent Cells
Table 6. Key Players of Electrocompetent Cells
Table 7. COVID-19 Impact Global Market: (Four Competent Cells Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Competent Cells Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Competent Cells Players to Combat Covid-19 Impact
Table 12. Global Competent Cells Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Competent Cells Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Competent Cells Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Competent Cells Market Share by Regions (2015-2020)
Table 16. Global Competent Cells Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Competent Cells Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Competent Cells Market Growth Strategy
Table 22. Main Points Interviewed from Key Competent Cells Players
Table 23. Global Competent Cells Revenue by Players (2015-2020) (Million US$)
Table 24. Global Competent Cells Market Share by Players (2015-2020)
Table 25. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Competent Cells as of 2019)
Table 26. Global Competent Cells by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Competent Cells Product Solution and Service
Table 29. Date of Enter into Competent Cells Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Competent Cells Market Size by Type (2015-2020) (Million US$)
Table 32. Global Competent Cells Market Size Share by Type (2015-2020)
Table 33. Global Competent Cells Revenue Market Share by Type (2021-2026)
Table 34. Global Competent Cells Market Size Share by Application (2015-2020)
Table 35. Global Competent Cells Market Size by Application (2015-2020) (Million US$)
Table 36. Global Competent Cells Market Size Share by Application (2021-2026)
Table 37. North America Key Players Competent Cells Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Competent Cells Market Share (2019-2020)
Table 39. North America Competent Cells Market Size by Type (2015-2020) (Million US$)
Table 40. North America Competent Cells Market Share by Type (2015-2020)
Table 41. North America Competent Cells Market Size by Application (2015-2020) (Million US$)
Table 42. North America Competent Cells Market Share by Application (2015-2020)
Table 43. Europe Key Players Competent Cells Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Competent Cells Market Share (2019-2020)
Table 45. Europe Competent Cells Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Competent Cells Market Share by Type (2015-2020)
Table 47. Europe Competent Cells Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Competent Cells Market Share by Application (2015-2020)
Table 49. China Key Players Competent Cells Revenue (2019-2020) (Million US$)
Table 50. China Key Players Competent Cells Market Share (2019-2020)
Table 51. China Competent Cells Market Size by Type (2015-2020) (Million US$)
Table 52. China Competent Cells Market Share by Type (2015-2020)
Table 53. China Competent Cells Market Size by Application (2015-2020) (Million US$)
Table 54. China Competent Cells Market Share by Application (2015-2020)
Table 55. Japan Key Players Competent Cells Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Competent Cells Market Share (2019-2020)
Table 57. Japan Competent Cells Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Competent Cells Market Share by Type (2015-2020)
Table 59. Japan Competent Cells Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Competent Cells Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Competent Cells Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Competent Cells Market Share (2019-2020)
Table 63. Southeast Asia Competent Cells Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Competent Cells Market Share by Type (2015-2020)
Table 65. Southeast Asia Competent Cells Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Competent Cells Market Share by Application (2015-2020)
Table 67. India Key Players Competent Cells Revenue (2019-2020) (Million US$)
Table 68. India Key Players Competent Cells Market Share (2019-2020)
Table 69. India Competent Cells Market Size by Type (2015-2020) (Million US$)
Table 70. India Competent Cells Market Share by Type (2015-2020)
Table 71. India Competent Cells Market Size by Application (2015-2020) (Million US$)
Table 72. India Competent Cells Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Competent Cells Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Competent Cells Market Share (2019-2020)
Table 75. Central & South America Competent Cells Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Competent Cells Market Share by Type (2015-2020)
Table 77. Central & South America Competent Cells Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Competent Cells Market Share by Application (2015-2020)
Table 79. Merck KGaA Company Details
Table 80. Merck KGaA Business Overview
Table 81. Merck KGaA Product
Table 82. Merck KGaA Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 83. Merck KGaA Recent Development
Table 84. Thermo Fisher Scientific Company Details
Table 85. Thermo Fisher Scientific Business Overview
Table 86. Thermo Fisher Scientific Product
Table 87. Thermo Fisher Scientific Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 88. Thermo Fisher Scientific Recent Development
Table 89. Agilent Technologies Company Details
Table 90. Agilent Technologies Business Overview
Table 91. Agilent Technologies Product
Table 92. Agilent Technologies Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 93. Agilent Technologies Recent Development
Table 94. Takara Bio Company Details
Table 95. Takara Bio Business Overview
Table 96. Takara Bio Product
Table 97. Takara Bio Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 98. Takara Bio Recent Development
Table 99. Promega Corporation Company Details
Table 100. Promega Corporation Business Overview
Table 101. Promega Corporation Product
Table 102. Promega Corporation Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 103. Promega Corporation Recent Development
Table 104. Beijing TransGen Biotech Company Details
Table 105. Beijing TransGen Biotech Business Overview
Table 106. Beijing TransGen Biotech Product
Table 107. Beijing TransGen Biotech Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 108. Beijing TransGen Biotech Recent Development
Table 109. GeneScript Corporation Company Details
Table 110. GeneScript Corporation Business Overview
Table 111. GeneScript Corporation Product
Table 112. GeneScript Corporation Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 113. GeneScript Corporation Recent Development
Table 114. Yeastern Biotech Business Overview
Table 115. Yeastern Biotech Product
Table 116. Yeastern Biotech Company Details
Table 117. Yeastern Biotech Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 118. Yeastern Biotech Recent Development
Table 119. New England Biolabs Company Details
Table 120. New England Biolabs Business Overview
Table 121. New England Biolabs Product
Table 122. New England Biolabs Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 123. New England Biolabs Recent Development
Table 124. QIAGEN N.V. Company Details
Table 125. QIAGEN N.V. Business Overview
Table 126. QIAGEN N.V. Product
Table 127. QIAGEN N.V. Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 128. QIAGEN N.V. Recent Development
Table 129. OriGene Technologies Company Details
Table 130. OriGene Technologies Business Overview
Table 131. OriGene Technologies Product
Table 132. OriGene Technologies Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 133. OriGene Technologies Recent Development
Table 134. Lucigen Company Details
Table 135. Lucigen Business Overview
Table 136. Lucigen Product
Table 137. Lucigen Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 138. Lucigen Recent Development
Table 139. Zymo Research Company Details
Table 140. Zymo Research Business Overview
Table 141. Zymo Research Product
Table 142. Zymo Research Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 143. Zymo Research Recent Development
Table 144. Bio-Rad Laboratories Company Details
Table 145. Bio-Rad Laboratories Business Overview
Table 146. Bio-Rad Laboratories Product
Table 147. Bio-Rad Laboratories Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 148. Bio-Rad Laboratories Recent Development
Table 149. Bioline Company Details
Table 150. Bioline Business Overview
Table 151. Bioline Product
Table 152. Bioline Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 153. Bioline Recent Development
Table 154. Delphi Genetics Company Details
Table 155. Delphi Genetics Business Overview
Table 156. Delphi Genetics Product
Table 157. Delphi Genetics Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 158. Delphi Genetics Recent Development
Table 159. IBA GmBH Company Details
Table 160. IBA GmBH Business Overview
Table 161. IBA GmBH Product
Table 162. IBA GmBH Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 163. IBA GmBH Recent Development
Table 164. Cell Applications Company Details
Table 165. Cell Applications Business Overview
Table 166. Cell Applications Product
Table 167. Cell Applications Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 168. Cell Applications Recent Development
Table 169. BioDynamics Laboratory Company Details
Table 170. BioDynamics Laboratory Business Overview
Table 171. BioDynamics Laboratory Product
Table 172. BioDynamics Laboratory Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 173. BioDynamics Laboratory Recent Development
Table 174. Scarab Genomics Company Details
Table 175. Scarab Genomics Business Overview
Table 176. Scarab Genomics Product
Table 177. Scarab Genomics Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 178. Scarab Genomics Recent Development
Table 179. GCC Biotech Company Details
Table 180. GCC Biotech Business Overview
Table 181. GCC Biotech Product
Table 182. GCC Biotech Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 183. GCC Biotech Recent Development
Table 184. SMOBIO Technology Company Details
Table 185. SMOBIO Technology Business Overview
Table 186. SMOBIO Technology Product
Table 187. SMOBIO Technology Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 188. SMOBIO Technology Recent Development
Table 189. Edge BioSystems Company Details
Table 190. Edge BioSystems Business Overview
Table 191. Edge BioSystems Product
Table 192. Edge BioSystems Revenue in Competent Cells Business (2015-2020) (Million US$)
Table 193. Edge BioSystems Recent Development
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Competent Cells Market Share by Type: 2020 VS 2026
Figure 2. Chemically Competent Cells Features
Figure 3. Electrocompetent Cells Features
Figure 4. Global Competent Cells Market Share by Application: 2020 VS 2026
Figure 5. Subcloning & Routine Cloning Case Studies
Figure 6. Phage Display Library Construction Case Studies
Figure 7. Toxic/Unstable DNA Cloning Case Studies
Figure 8. High-Throughput Cloning Case Studies
Figure 9. Protein Expression Case Studies
Figure 10. Mutagenesis Case Studies
Figure 11. Single-Stranded DNA Production Case Studies
Figure 12. Bacmid creation Case Studies
Figure 13. Cre-lox recombination (PIR1/PIR2) Case Studies
Figure 14. Competent Cells Report Years Considered
Figure 15. Global Competent Cells Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Competent Cells Market Share by Regions: 2020 VS 2026
Figure 17. Global Competent Cells Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Competent Cells Market Share by Players in 2019
Figure 20. Global Top Competent Cells Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Competent Cells as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Competent Cells Revenue in 2019
Figure 22. North America Competent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Competent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Competent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Competent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Competent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Competent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Competent Cells Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Merck KGaA Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 31. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Thermo Fisher Scientific Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 33. Agilent Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Agilent Technologies Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 35. Takara Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Takara Bio Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 37. Promega Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Promega Corporation Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 39. Beijing TransGen Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Beijing TransGen Biotech Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 41. GeneScript Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. GeneScript Corporation Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 43. Yeastern Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Yeastern Biotech Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 45. New England Biolabs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. New England Biolabs Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 47. QIAGEN N.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. QIAGEN N.V. Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 49. OriGene Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. OriGene Technologies Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 51. Lucigen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Lucigen Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 53. Zymo Research Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Zymo Research Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 55. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 57. Bioline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Bioline Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 59. Delphi Genetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Delphi Genetics Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 61. IBA GmBH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. IBA GmBH Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 63. Cell Applications Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Cell Applications Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 65. BioDynamics Laboratory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. BioDynamics Laboratory Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 67. Scarab Genomics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Scarab Genomics Revenue Growth Rate in Competent Cells Business (2015-2020)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • Global Cytokine Inhibitor Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Cytokine Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The development prospects of cytokine inhibitors are very broad, and these drugs have many medical applications and researches. Cytokine inhibitors can reduce The activity of cytokines, thereby inhibiting their role in immune responses and reducing The activation of immune cells and The occurrence o......
  • Global Microbial Growth Media Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Microbial Growth Media is a nutrient component required by microorganisms, containing a variety of trace elements and trace elements, such as copper, iron, zinc, cobalt, manganese, etc. The global Microbial Growth Media market was valued at US$ 8007 million in 2023 and is anticipated to reach US$ 11530 million by 2030, witnessing a CAGR of 5.3% during The forecast period 2024-2030. The market for microbial growth media is essential in microbiology and biotechnology rese......
  • Global Protein Biochip Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    Protein Biochip is a small Protein array used to quickly detect a large number of unknown proteins. It works in a similar way to a DNA chip. First, a large number of known proteins (such as monoclonal antibodies) are placed on a small substrate and then exposed to and reacted with The unknown protein sample. Due to The specific binding between The antigen and The antibody, it can finally be detected by means of laser. The global Protein Biochip market was valued at US$ 145 million i......
  • Global Isothermal Nucleic Acid Amplification Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 103
    Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get The statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish The reaction. T......
  • Global Microfluidics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Microfluidics market size was valued at US$ 3118.7 million in 2023. With growing demand in downstream market, the Microfluidics is forecast to a readjusted size of US$ 7707.1 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Microfluidics market. Microfluidics are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122
    According to our LPI (LP Information) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at US$ 6141.3 million in 2023. With growing demand in downstream market, the Isothermal Nucleic Acid Amplification Technology (INAAT) is forecast to a readjusted size of US$ 11250 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Isothermal Nucleic Acid Amplification Technol......
  • Global Cytokines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Cytokines market size was valued at US$ 203730 million in 2023. With growing demand in downstream market, the Cytokines is forecast to a readjusted size of US$ 611910 million by 2030 with a CAGR of 17.0% during review period. The research report highlights the growth potential of the global Cytokines market. Cytokines are expected to show stable growth in the future market. However, product differentiation, reducing costs, an......
  • Global Western Blot Imagers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Western Blot Imagers market size was valued at US$ 406 million in 2023. With growing demand in downstream market, the Western Blot Imagers is forecast to a readjusted size of US$ 578.4 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Western Blot Imagers market. Western Blot Imagers are expected to show stable growth in the future market. However, prod......
  • Global Procalcitonin Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Procalcitonin Antibody market size was valued at US$ million in 2023. With growing demand in downstream market, the Procalcitonin Antibody is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Procalcitonin Antibody market. Procalcitonin Antibody are expected to show stable growth in the future market. However, product di......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs